Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4504-87-4

Post Buying Request

4504-87-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4504-87-4 Usage

Chemical Properties

Pale Yellow Solid

Uses

Doxepin intermediate. A photodecomposition product of Doxepin.

Check Digit Verification of cas no

The CAS Registry Mumber 4504-87-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,0 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 4504-87:
(6*4)+(5*5)+(4*0)+(3*4)+(2*8)+(1*7)=84
84 % 10 = 4
So 4504-87-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H10O2/c15-14-11-6-2-1-5-10(11)9-16-13-8-4-3-7-12(13)14/h1-8H,9H2

4504-87-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Dibenzo[b,e]oxepin-11(6H)-one

1.2 Other means of identification

Product number -
Other names 6H-benzo[c][1]benzoxepin-11-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4504-87-4 SDS

4504-87-4Synthetic route

2-(phenoxymethyl)benzoic acid
724-98-1

2-(phenoxymethyl)benzoic acid

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
With trifluoromethylsulfonic anhydride; boron trifluoride diethyl etherate In dichloromethane at 40℃; for 2h;98%
With boron trifluoride diethyl etherate; trifluoroacetic anhydride In dichloromethane at 20℃; for 1h;80.7%
With boron trifluoride diethyl etherate; trifluoroacetic anhydride In dichloromethane for 1h; Ambient temperature;79%
2-((2-bromobenzyl)oxy)benzonitrile

2-((2-bromobenzyl)oxy)benzonitrile

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Stage #1: 2-[(2-bromobenzyl)oxy]benzonitrile With n-butyllithium In tetrahydrofuran at -78℃; for 1h; Inert atmosphere;
Stage #2: With hydrogenchloride In tetrahydrofuran; water
74%
C14H10BrNO

C14H10BrNO

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Stage #1: C14H10BrNO With n-butyllithium In tetrahydrofuran at -78℃; for 1h; Inert atmosphere;
Stage #2: With hydrogenchloride In tetrahydrofuran; water
73%
doxepin hydrochloride
1229-29-4

doxepin hydrochloride

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
With dihydrogen peroxide for 1h; Heating;
2-benzofuran-1(3H)-one
87-41-2

2-benzofuran-1(3H)-one

<4-oxy-phthalic acid >-anhydride

<4-oxy-phthalic acid >-anhydride

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaH / dimethylformamide
1.2: 70.8 percent / dimethylformamide; benzene / 24 h / Heating
2.1: 80.7 percent / trifluoroacetic anhydride; boron trifluoride etherate / CH2Cl2 / 1 h / 20 °C
View Scheme
phenol
108-95-2

phenol

2-chlorobenzylhalide

2-chlorobenzylhalide

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaH / dimethylformamide
1.2: 70.8 percent / dimethylformamide; benzene / 24 h / Heating
2.1: 80.7 percent / trifluoroacetic anhydride; boron trifluoride etherate / CH2Cl2 / 1 h / 20 °C
View Scheme
sodium phenoxide
139-02-6

sodium phenoxide

monochloroacetate sodium

monochloroacetate sodium

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: P2O5 / ethanol
View Scheme
2-ethoxycarbonylbenzyl bromide
7115-91-5

2-ethoxycarbonylbenzyl bromide

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: P2O5 / ethanol
View Scheme
Multi-step reaction with 4 steps
1: sodium ethanolate / ethanol / 6.5 h / Reflux
2: sodium hydroxide; water / ethanol / 1 h / Reflux
3: thionyl chloride / 1 h / Reflux
4: aluminum (III) chloride / dichloromethane / 0.25 h / 0 °C
View Scheme
2-benzofuran-1(3H)-one
87-41-2

2-benzofuran-1(3H)-one

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1 h / 200 °C
2: 79 percent / (CF3CO)2O, BF3*Et2O / CH2Cl2 / 1 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1: sodium methylate / ethanol / 4 h / 55 °C
2: aluminum (III) chloride / dimethyl sulfoxide / 8 h / 100 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium hydride / N,N-dimethyl-formamide; benzene / 24 h / Inert atmosphere; Schlenk technique; Reflux
2: Dichloromethyl methyl ether; iron(II) chloride / dichloromethane / 20 °C / Inert atmosphere; Schlenk technique
View Scheme
sodium phenoxide
139-02-6

sodium phenoxide

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1 h / 200 °C
2: 79 percent / (CF3CO)2O, BF3*Et2O / CH2Cl2 / 1 h / Ambient temperature
View Scheme
2-hydroxybromobenzene
95-56-7

2-hydroxybromobenzene

2-(bromomethyl)benzonitrile
22115-41-9

2-(bromomethyl)benzonitrile

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / N,N-dimethyl-formamide
2: n-butyllithium / tetrahydrofuran / 1 h / -78 °C / Inert atmosphere
View Scheme
methyl 2-bromomethylbenzoate
2417-73-4

methyl 2-bromomethylbenzoate

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium methylate / ethanol / 4 h / 55 °C
2: sodium hydroxide / water / 6 h / 35 °C
3: aluminum (III) chloride / dimethyl sulfoxide / 8 h / 100 °C
View Scheme
Multi-step reaction with 3 steps
1: sodium methylate / ethanol / 4 h / 55 °C
2: sodium hydroxide / water / 6 h / 35 °C
3: trifluoroacetic anhydride / 1,2-dichloro-ethane / 8 h / 100 °C
View Scheme
methyl 2-(phenoxymethyl)benzoate
866996-44-3

methyl 2-(phenoxymethyl)benzoate

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide / water / 6 h / 35 °C
2: aluminum (III) chloride / dimethyl sulfoxide / 8 h / 100 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium hydroxide / water / 6 h / 35 °C
2: trifluoroacetic anhydride / 1,2-dichloro-ethane / 8 h / 100 °C
View Scheme
2-Methyl-benzoic acid methyl ester
89-71-4

2-Methyl-benzoic acid methyl ester

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: N-Bromosuccinimide / Petroleum ether / 2.5 h / 15 °C
2: sodium methylate / ethanol / 4 h / 55 °C
3: sodium hydroxide / water / 6 h / 35 °C
4: aluminum (III) chloride / dimethyl sulfoxide / 8 h / 100 °C
View Scheme
o-(chloromethyl)benzoic acid methyl ester
34040-62-5

o-(chloromethyl)benzoic acid methyl ester

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium methylate / ethanol / 4.5 h / 55 °C
2: sodium hydroxide / water / 6 h / 35 °C
3: trifluoroacetic anhydride / 1,2-dichloro-ethane / 8 h / 100 °C
View Scheme
phenol
108-95-2

phenol

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium methylate / ethanol / 4 h / 55 °C
2: sodium hydroxide / water / 6 h / 35 °C
3: trifluoroacetic anhydride / 1,2-dichloro-ethane / 8 h / 100 °C
View Scheme
Multi-step reaction with 3 steps
1: sodium methylate / ethanol / 4.5 h / 55 °C
2: sodium hydroxide / water / 6 h / 35 °C
3: trifluoroacetic anhydride / 1,2-dichloro-ethane / 8 h / 100 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium hydride / N,N-dimethyl-formamide; benzene / 24 h / Inert atmosphere; Schlenk technique; Reflux
2: Dichloromethyl methyl ether; iron(II) chloride / dichloromethane / 20 °C / Inert atmosphere; Schlenk technique
View Scheme
o-phthalic dicarboxaldehyde
643-79-8

o-phthalic dicarboxaldehyde

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: water / 0.75 h / 7 °C
2: sulfuric acid / 3 h / 70 °C
3: sodium methylate / ethanol / 4 h / 55 °C
4: aluminum (III) chloride / dimethyl sulfoxide / 8 h / 100 °C
View Scheme
2-(hydroxymethyl)benzoic acid
612-20-4

2-(hydroxymethyl)benzoic acid

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sulfuric acid / 3 h / 70 °C
2: sodium methylate / ethanol / 4 h / 55 °C
3: aluminum (III) chloride / dimethyl sulfoxide / 8 h / 100 °C
View Scheme
2-phenoxymethylbenzoyl chloride
21733-94-8

2-phenoxymethylbenzoyl chloride

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
With aluminum (III) chloride In dichloromethane at 0℃; for 0.25h; Friedel-Crafts Acylation;
ortho-methylbenzoic acid
118-90-1

ortho-methylbenzoic acid

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: potassium carbonate / N,N-dimethyl-formamide / 24 h / 20 °C
2: N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) / tetrachloromethane / 3.5 h / Reflux
3: sodium ethanolate / ethanol / 6.5 h / Reflux
4: sodium hydroxide; water / ethanol / 1 h / Reflux
5: thionyl chloride / 1 h / Reflux
6: aluminum (III) chloride / dichloromethane / 0.25 h / 0 °C
View Scheme
ethyl 2-methylbenzoate
87-24-1

ethyl 2-methylbenzoate

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) / tetrachloromethane / 3.5 h / Reflux
2: sodium ethanolate / ethanol / 6.5 h / Reflux
3: sodium hydroxide; water / ethanol / 1 h / Reflux
4: thionyl chloride / 1 h / Reflux
5: aluminum (III) chloride / dichloromethane / 0.25 h / 0 °C
View Scheme
2-Phenoxymethyl-benzoic acid ethyl ester
4504-85-2

2-Phenoxymethyl-benzoic acid ethyl ester

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium hydroxide; water / ethanol / 1 h / Reflux
2: thionyl chloride / 1 h / Reflux
3: aluminum (III) chloride / dichloromethane / 0.25 h / 0 °C
View Scheme
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

p-trifluoromethylphenyl bromide
402-43-7

p-trifluoromethylphenyl bromide

11-[4-(trifluoromethyl)phenyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol

11-[4-(trifluoromethyl)phenyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran; hexane at -78 - 20℃; for 28h; Inert atmosphere;99%
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

11-hydroxy-6,11-dihydrodibenzo[b,e]oxepine
5251-26-3

11-hydroxy-6,11-dihydrodibenzo[b,e]oxepine

Conditions
ConditionsYield
With sodium tetrahydroborate86%
With sodium tetrahydroborate In methanol at 0℃; for 0.333333h;
With sodium tetrahydroborate In methanol at 20℃; for 2h;
bromobenzene
108-86-1

bromobenzene

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

11-phenyl-6,11-dihydro-5H-dibenzo[a,d]oxepin-11-ol

11-phenyl-6,11-dihydro-5H-dibenzo[a,d]oxepin-11-ol

Conditions
ConditionsYield
Stage #1: bromobenzene With magnesium In tetrahydrofuran for 0.333333h;
Stage #2: 6,11-dihydrodibenz[b,e]oxepin-11-one In tetrahydrofuran for 0.5h; Heating;
85%
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

3-(1,1-dimethylethoxy)-1-chloropropane
1190-17-6

3-(1,1-dimethylethoxy)-1-chloropropane

11-(3-tertbutoxypropyl)-11-hydroxy-6,11-dihydrodibenzo-[b,e]-oxepine
1612-63-1

11-(3-tertbutoxypropyl)-11-hydroxy-6,11-dihydrodibenzo-[b,e]-oxepine

Conditions
ConditionsYield
With magnesium In diethyl ether for 1h; Heating / reflux;80%
Stage #1: 3-(1,1-dimethylethoxy)-1-chloropropane With magnesium In diethyl ether
Stage #2: 6,11-dihydrodibenz[b,e]oxepin-11-one In diethyl ether for 1h; Heating / reflux;
Stage #3: With water; ammonium chloride In diethyl ether
80%
Stage #1: 3-(1,1-dimethylethoxy)-1-chloropropane With magnesium In diethyl ether
Stage #2: 6,11-dihydrodibenz[b,e]oxepin-11-one In diethyl ether for 1h; Heating / reflux;
Stage #3: With ammonium chloride In diethyl ether
80%
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

5-phenyl-2H-1,2,3,4-tetrazole
18039-42-4

5-phenyl-2H-1,2,3,4-tetrazole

6-(5-phenyl-2H-tetrazol-2-yl)dibenzo[b,e]oxepin-11(6H)-one

6-(5-phenyl-2H-tetrazol-2-yl)dibenzo[b,e]oxepin-11(6H)-one

Conditions
ConditionsYield
With tert.-butylhydroperoxide; water; tetra-(n-butyl)ammonium iodide at 90℃; for 9h; regioselective reaction;64%
4-chloro-1-methylpiperidine
5570-77-4

4-chloro-1-methylpiperidine

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

11-(1-methyl-piperidin-4-yl)-6,11-dihydro-dibenzo[b,e]oxepin-11-ol
51582-48-0

11-(1-methyl-piperidin-4-yl)-6,11-dihydro-dibenzo[b,e]oxepin-11-ol

Conditions
ConditionsYield
(i) EtMgBr, THF, (heating), (ii) /BRN= 1344817/, (heating); Multistep reaction;
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

methylenedimethyl sulfurane
6814-64-8, 40651-06-7

methylenedimethyl sulfurane

C15H12O2
105666-56-6

C15H12O2

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran; dimethyl sulfoxide for 10h; Ambient temperature;
3-(N,N-dimethylamino)propylmagnesium chloride
19070-16-7

3-(N,N-dimethylamino)propylmagnesium chloride

6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

doxepin hydrochloride
1229-29-4

doxepin hydrochloride

Conditions
ConditionsYield
With hydrogenchloride 1.) THF, toluene, 65 deg C, 2 h, 2.) 1 h, 3.) 75 deg C, 1.5 h, ethanol; Multistep reaction;
Stage #1: 3-(N,N-dimethylamino)propylmagnesium chloride; 6,11-dihydrodibenz[b,e]oxepin-11-one In tetrahydrofuran; toluene at 65℃; for 2h;
Stage #2: With hydrogenchloride at 65℃; for 1.5h;
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

3-(Dimethylamino)propyl chloride
109-54-6

3-(Dimethylamino)propyl chloride

doxepin hydrochloride
1229-29-4

doxepin hydrochloride

Conditions
ConditionsYield
With hydrogenchloride; 1,1-Dibromoethane; magnesium 1) THF, reflux; 2) THF, reflux;; Yield given. Multistep reaction;
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

(E)-Desmethyldoxepin
67035-76-1

(E)-Desmethyldoxepin

Conditions
ConditionsYield
Stage #1: [3-(methylamino)propyl](triphenyl)phosphonium bromide hydrobromide With n-butyllithium In tetrahydrofuran; n-heptane for 1.5h;
Stage #2: 6,11-dihydrodibenz[b,e]oxepin-11-one In tetrahydrofuran; n-heptane for 10h; Heating / reflux;
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

6,11-dihydrodibenz[b,e]oxepin

6,11-dihydrodibenz[b,e]oxepin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 86 percent / NaBH4
2: H2 / 10percent Pd-C / diethyl ether / 5 h / 1875.1 Torr / Ambient temperature
View Scheme
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

6,11-Dihydro-dibenzo[b,e]oxepine-11-carbaldehyde
154775-82-3

6,11-Dihydro-dibenzo[b,e]oxepine-11-carbaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaH / dimethylsulfoxide; tetrahydrofuran / 10 h / Ambient temperature
2: BF3*Et2O / CH2Cl2 / 5 h
View Scheme
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

6,11-dihydrodibenzoxepin-11-carboxylic acid
144170-65-0

6,11-dihydrodibenzoxepin-11-carboxylic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: NaH / dimethylsulfoxide; tetrahydrofuran / 10 h / Ambient temperature
2: BF3*Et2O / CH2Cl2 / 5 h
3: KMnO4 / acetone; 2-methyl-propan-2-ol / 1.5 h / pH 6.86
View Scheme
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

N-(2,6-diisopropylphenyl)-6,11-dihydrodibenzoxepin-11-carboxamide

N-(2,6-diisopropylphenyl)-6,11-dihydrodibenzoxepin-11-carboxamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: NaH / dimethylsulfoxide; tetrahydrofuran / 10 h / Ambient temperature
2: BF3*Et2O / CH2Cl2 / 5 h
3: KMnO4 / acetone; 2-methyl-propan-2-ol / 1.5 h / pH 6.86
4: 1.) oxalyl chloride, 2.) NEt3, 4-(N,N-dimethylamino)pyridine / 1.) CH2Cl2, 8 h, 2.) CH2Cl2, RT, 1.5 h
View Scheme
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

11-chloro-6,11-dihydrodibenzo[b,e]oxepine
19373-88-7

11-chloro-6,11-dihydrodibenzo[b,e]oxepine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaBH4 / methanol / 0.33 h / 0 °C
2: SOCl2 / 0.17 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1: sodium tetrahydroborate / methanol / 2 h / 20 °C
2: thionyl chloride / dichloromethane / 1 h / 0 - 20 °C
View Scheme
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

1-(6,11-Dihydrodibenzoxepin-11-yl)piperazine
129717-22-2

1-(6,11-Dihydrodibenzoxepin-11-yl)piperazine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: NaBH4 / methanol / 0.33 h / 0 °C
2: SOCl2 / 0.17 h / Ambient temperature
3: CH2Cl2 / 2 h / Ambient temperature
View Scheme
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

1-(6,11-Dihydro-dibenzo[b,e]oxepin-11-yl)-4-((E)-3-phenyl-allyl)-piperazine; compound with (Z)-but-2-enedioic acid
114312-42-4, 139305-25-2

1-(6,11-Dihydro-dibenzo[b,e]oxepin-11-yl)-4-((E)-3-phenyl-allyl)-piperazine; compound with (Z)-but-2-enedioic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: NaBH4 / methanol / 0.33 h / 0 °C
2: SOCl2 / 0.17 h / Ambient temperature
3: 67 percent / CH2Cl2 / 1 h / Ambient temperature
View Scheme
6,11-dihydrodibenz[b,e]oxepin-11-one
4504-87-4

6,11-dihydrodibenz[b,e]oxepin-11-one

1-(6,11-Dihydro-dibenzo[b,e]oxepin-11-yl)-4-(3-phenyl-prop-2-ynyl)-piperazine; compound with (Z)-but-2-enedioic acid
139305-71-8

1-(6,11-Dihydro-dibenzo[b,e]oxepin-11-yl)-4-(3-phenyl-prop-2-ynyl)-piperazine; compound with (Z)-but-2-enedioic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: NaBH4 / methanol / 0.33 h / 0 °C
2: SOCl2 / 0.17 h / Ambient temperature
3: CH2Cl2 / 2 h / Ambient temperature
4: 18 percent / toluene / 8 h / Heating
View Scheme

4504-87-4Relevant articles and documents

Extractive spectrophotometric methods for the determination of doxepin hydrochloride in pharmaceutical preparations using titanium (IV) and iron (III) thiocyanate complexes

Misiuk, Wieslawa

, p. 61 - 69 (2005)

Two simple, precise, and accurate extractive spectrophotometric methods have been developed for the determination of doxepin hydrochloride in pharmaceutical preparations. The methods are based on the formation of ion association complexes of doxepin with

A New Antagonist of Caenorhabditis elegans Glutamate-Activated Chloride Channels With Anthelmintic Activity

Bouzat, Cecilia,Castro, María Julia,Faraoni, María Belén,Gerbino, Darío,Turani, Ornella

, (2020/09/07)

Nematode parasitosis causes significant mortality and morbidity in humans and considerable losses in livestock and domestic animals. The acquisition of resistance to current anthelmintic drugs has prompted the search for new compounds for which the free-living nematode Caenorhabditis elegans has emerged as a valuable platform. We have previously synthetized a small library of oxygenated tricyclic compounds and determined that dibenzo[b,e]oxepin-11(6H)-one (doxepinone) inhibits C. elegans motility. Because doxepinone shows potential anthelmintic activity, we explored its behavioral effects and deciphered its target site and mechanism of action on C. elegans. Doxepinone reduces swimming rate, induces paralysis, and decreases the rate of pharyngeal pumping required for feeding, indicating a marked anthelmintic activity. To identify the main drug targets, we performed an in vivo screening of selected strains carrying mutations in Cys-loop receptors involved in worm locomotion for determining resistance to doxepinone effects. A mutant strain that lacks subunit genes of the invertebrate glutamate-gated chloride channels (GluCl), which are targets of the widely used antiparasitic ivermectin (IVM), is resistant to doxepinone effects. To unravel the molecular mechanism, we measured whole-cell currents from GluClα1/β receptors expressed in mammalian cells. Glutamate elicits macroscopic currents whereas no responses are elicited by doxepinone, indicating that it is not an agonist of GluCls. Preincubation of the cell with doxepinone produces a statistically significant decrease of the decay time constant and net charge of glutamate-elicited currents, indicating that it inhibits GluCls, which contrasts to IVM molecular actions. Thus, we identify doxepinone as an attractive scaffold with promising anthelmintic activity and propose the inhibition of GluCls as a potential anthelmintic mechanism of action.

Iron(II) promoted direct synthesis of dibenzo[b,e]oxepin-11(6H)-one derivatives with biological activity. A short synthesis of doxepin

Scoccia, Jimena,Castro, M. Julia,Faraoni, M. Belén,Bouzat, Cecilia,Martín, Víctor S.,Gerbino, Darío C.

, p. 2913 - 2922 (2017/04/26)

A novel and efficient synthesis of dibenzo[b,e]oxepin-11(6H)-ones by direct intramolecular ortho-acylation from readily available 2-(phenoxymethyl)benzoic acids was developed. The method takes advantage of a newly developed cooperative system consisting of sustainable FeCl2 and Cl2CHOCH3 as the key components. This methodology is compatible with a wide variety of functional groups in good to excellent yields and high regioselectivity. The synthetic application of new protocol was extended to the synthesis of known tricyclic drug doxepin as well as a small library of oxepin based derivatives. For the first time, the obtained dibenzo[b,e]oxepinone derivatives were evaluated for their biological activities on the free-living nematode Caenorhabditis elegans as an effective and cost-efficient model system for anthelmintic discovery.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4504-87-4